• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research for Dopaminergic Neurotransmission Using Positron Emission Tomography

Research Project

Project/Area Number 08671037
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionKyushu University

Principal Investigator

KUWABARA Yasuo  Faculty of Medicine, Kyushu University Associate Professor, 医学部, 助教授 (30150436)

Co-Investigator(Kenkyū-buntansha) NAKAGAWA Makoto  Faculty of Medicine, Research Associate, 医学部, 医員
YOSHIDA Tsuyoshi  Faculty of Medicine, Research Associate, 医学部, 助手 (40284509)
FUKUMURA Toshimitsu  Faculty of Medicine, Research Associate, 医学部, 助手 (90199266)
SASAKI Masayuki  Faculty of Medicine, Research Associate, 医学部, 助手 (40240907)
一矢 有一  九州大学, 医学部, 助教授 (00117425)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1997: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1996: ¥1,300,000 (Direct Cost: ¥1,300,000)
Keywordspositron emission tomography / dopamin D_2 receptor / C-11 raclopride / effect of normal aging / Parkinson's disease
Research Abstract

We developed a synthesis system for production of C-11 raclopride, and measured dopamine D2 receptor in normal volunteers and patients with Parkinsonian symptoms. The subjects consisted 10 normal volunteers and 4 patients, including 2 patients with striatonigral degeneration, one patient with corticobasal degeneration and Parkinson's disease. 7.9 - 22.4 mCi of C-11 raclopride was intravenously administered as a bolus. The data were collected for every 2 min (0-20 min), every 4 min (20-60 min) and 15 min (63-78 min). Striatal C-11 raclopride uptake was evaluated by the equilibrium method with individually determined plateau time. We used the cerebellum as a reference region of non-specific binding site. There was no significant effect of C-11 raclopride specific activity on the striatal/cerebellar uptake ratio in a range of 378 to 1800 mCi/ mu mol. In normal volunteers, the striatal/cerebellar uptake ratio gradually decreased with age at a rate of 0.5 %/year. The striatal/cerebellar uptake ratio decreased in a patient with striato-nigral degeneration and a patient with corticobasal degeneration. It was preserved in a patient with striatonigral degeneration and a patient with Parkinson's disease. C-11 raclopride is thought to be useful for evaluating D_2 receptor in patients with Parkinsonian symptoms.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi